Optimum treatment of congenital cytomegalovirus infection

Identification of Symptomatic Fetuses Infected with Cytomegalovirus Using Amniotic Fluid Peptide Biomarkers

(2016) Cyrille Desveaux et al.   PLoS Pathogens

Lenticulostriated vasculopathy is a high-risk marker for hearing loss in congenital cytomegalovirus infections

(2015) Efraim Bilavsky et al.   ACTA PAEDIATRICA

Comparison of the LIAISON ® CMV IgG Avidity II and the VIDAS ® CMV IgG Avidity II assays for the diagnosis of primary infection in pregnant women

(2015) Yann Sellier et al.   JOURNAL OF CLINICAL VIROLOGY

Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

(2015) David W. Kimberlin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Detection of Congenital Cytomegalovirus Infection by Real-Time Polymerase Chain Reaction Analysis of Saliva or Urine Specimens

(2014) S. A. Ross et al.   JOURNAL OF INFECTIOUS DISEASES

A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus

(2014) Maria Grazia Revello et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hyperimmune Globulin to Prevent Congenital CMV Infection

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

(2014) Roy F. Chemaly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?

(2014) Michael J. Cannon et al.   REVIEWS IN MEDICAL VIROLOGY

Testicular Effects Following In Utero Exposure to the Antivirals Acyclovir and Ganciclovir in Rats

(2014) Fabíola Nihi et al.   TOXICOLOGICAL SCIENCES

Prediction of Fetal Infection in Cases With Cytomegalovirus Immunoglobulin M in the First Trimester of Pregnancy: A Retrospective Cohort

(2013) Marianne Leruez-Ville et al.   CLINICAL INFECTIOUS DISEASES

Management of Pregnancies with Confirmed Cytomegalovirus Fetal Infection

(2013) Guillaume Benoist et al.   FETAL DIAGNOSIS AND THERAPY

Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection

(2013) K. Yeon Choi et al.   JOURNAL OF CLINICAL VIROLOGY

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

(2013) Francisco M. Marty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fetal Human Cytomegalovirus Transmission Correlates with Delayed Maternal Antibodies to gH/gL/pUL128-130-131 Complex during Primary Infection

(2013) Daniele Lilleri et al.   PLoS One

The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model

(2013) Jutte J. C. de Vries et al.   REVIEWS IN MEDICAL VIROLOGY

Risk of cytomegalovirus-associated sequelae in relation to time of infection and findings on prenatal imaging

(2013) S. Lipitz et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial

(2012) D. J. Winston et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Early Primary Cytomegalovirus Infection in Pregnancy: Maternal Hyperimmunoglobulin Therapy Improves Outcomes Among Infants at 1 Year of Age

(2012) S. Visentin et al.   CLINICAL INFECTIOUS DISEASES

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

(2012) Mohamed A Kharfan-Dabaja et al.   LANCET INFECTIOUS DISEASES

Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation

(2012) Paul D Griffiths   LANCET INFECTIOUS DISEASES

Is lenticulostriated vasculopathy a sign of central nervous system insult in infants with congenital CMV infection?

(2011) J. Amir et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Evidence based management guidelines for the detection and treatment of congenital CMV

(2011) S. Kadambari et al.   EARLY HUMAN DEVELOPMENT

Ganciclovir treatment in children: evidence of subtherapeutic levels

(2011) Suzanne Luck et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: A 20-year experience

(2011) Maria Grazia Revello et al.   JOURNAL OF CLINICAL VIROLOGY

Immunoglobulin Therapy of Fetal Cytomegalovirus Infection Occurring in the First Half of Pregnancy--A Case-Control Study of the Outcome in Children

(2011) G. Nigro et al.   JOURNAL OF INFECTIOUS DISEASES

Modeling of Human Cytomegalovirus Maternal-Fetal Transmission in a Novel Decidual Organ Culture

(2011) Y. Weisblum et al.   JOURNAL OF VIROLOGY

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

(2011) Paul D Griffiths et al.   LANCET

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

(2011) Francisco M Marty et al.   LANCET INFECTIOUS DISEASES

Saliva Polymerase-Chain-Reaction Assay for Cytomegalovirus Screening in Newborns

(2011) Suresh B. Boppana et al.   NEW ENGLAND JOURNAL OF MEDICINE

Brain magnetic resonance findings in symptomatic congenital cytomegalovirus infection

(2011) Renzo Manara et al.   PEDIATRIC RADIOLOGY

Maribavir and human cytomegalovirus—what happened in the clinical trials and why might the drug have failed?

(2011) Francisco M Marty et al.   Current Opinion in Virology

Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood

(2010) E Fabbri et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Attribution of Congenital Cytomegalovirus Infection to Primary Versus Non-Primary Maternal Infection

(2010) C. Wang et al.   CLINICAL INFECTIOUS DISEASES

Use of Acyclovir, Valacyclovir, and Famciclovir in the First Trimester of Pregnancy and the Risk of Birth Defects

(2010) Björn Pasternak   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays

(2010) Maria Grazia Revello et al.   JOURNAL OF CLINICAL VIROLOGY

Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system

(2009) Sara E. Oliver et al.   JOURNAL OF CLINICAL VIROLOGY

Vaccine Prevention of Maternal Cytomegalovirus Infection

(2009) Robert F. Pass et al.   NEW ENGLAND JOURNAL OF MEDICINE

The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus

(2008) G Benoist et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Pharmacokinetic and Pharmacodynamic Assessment of Oral Valganciclovir in the Treatment of Symptomatic Congenital Cytomegalovirus Disease

(2008) David W. Kimberlin et al.   JOURNAL OF INFECTIOUS DISEASES

Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up

(2008) A Lackner et al.   JOURNAL OF LARYNGOLOGY AND OTOLOGY

Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection

(2008) Olivier Picone et al.   PRENATAL DIAGNOSIS

Cytomegalovirus-related fetal brain lesions: comparison between targeted ultrasound examination and magnetic resonance imaging

(2008) G. Benoist et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY